Rights and permissions
About this article
Cite this article
Ondansetron prophylaxis - costs outweigh benefits. Pharmacoecon. Outcomes News 10, 7 (1994). https://doi.org/10.1007/BF03289809
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03289809